About this trial
A prospective, non-significant risk study designed to validate the performance of the DistaSense Contactless Sensor and algorithm for detecting heart rate and respiratory rate, compared to gold standard reference technology.
Eligibility criteria
Qualifiers
Age ≥ 22 years
Fluent in English
Willing and cognitively able to provide informed consent
BMI < 36
Disqualifiers
Pregnant
Sufficiently broken, damaged or irritated skin or rashes near the sensor application sites such that investigator believes should be precluded from enrollment
Subjects with electronic implants of any kind (e.g. pacemaker)
Subjects that are Life Detection Technology employees or shareholders, or family of a Life Detection Technology employee or shareholder
Trial design
Treatments tested in this trial
- DistaSense and Polysomnography
Treatment groups
Sponsors and collaborators
Life Detection Technologies
Lead sponsor
Nilo Medical Consulting Group
Collaborator